«
»

Amgen falls on new Medicare policy

Shares of Amgen Inc. fell Tuesday after the agency that runs Medicare outlined a new policy which analysts say will sharply limit reimbursements for Amgen’s anemia drug Aranesp.

Read more here…

Leave a Reply

You must be logged in to post a comment.